BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

United States, BioTech

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

US Bio-Pharma Company Gilead Sciences buys Oxford Biotech Company MiroBio for $405 Million

The best Articles in our Network

Netherlands

Ver.iD from Amsterdam secures €2M to transform Digital Identity Verification Across Europe

Germany

Lilium from Munich secures Funding to restart Operations Following Insolvency

Germany

Canada struggles 2024 to define its Role in the Global AI Race amid Funding and Strategy Challenges

Germany

VÆRIDION from Germany raises €14M to develop Zero-Emission Electric Microliner

World’s Inspiring Leaders

The Visionaries behind OnlyFans: Tim Stokely’s Idea and Leonid Radvinsky’s Leadership That Changed the Creator Economy

Canada

Realize Capital Partners commits $32.5M in second Round of Social Finance Fund Investments

Previous

Next